[1]
Armstrong , A., Strober , B., Gordon , K. , Zhuo, J., Becker, B. , Kisa, R., Throup, J., Kim, J. and Papp, K. 2021. Deucravacitinib Improves Psoriasis Symptoms and Signs Diary Domain Scores in Patients With Moderate to Severe Plaque Psoriasis: Results From the Phase 3 POETYK PSO-1 and POETYK PSO-2 Studies. SKIN The Journal of Cutaneous Medicine. 5, 6 (Nov. 2021), s38. DOI:https://doi.org/10.25251/skin.5.supp.38.